About this item:

230 Views | 286 Downloads

Author Notes:

Corresponding Author: Toyya A. Pujol, MS, 755 Ferst Dr, NW, Atlanta, GA 30332. Telephone: 917-586-8682. Email: pujol@gatech.edu.

We thank Gabriella Runnels for her assistance in the initial data querying.

Dr. Julie Swann is currently the department head of Industrial and Systems Engineering at North Carolina State University.

Subjects:

Research Funding:

This work was supported by the National Institutes of Health (grant no. T32, GM105490).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Public, Environmental & Occupational Health
  • UNITED-STATES
  • UNINTENDED PREGNANCY
  • HEALTH-CARE
  • DISEASE
  • TRENDS

Medicaid Claims for Contraception Among Women With Medical Conditions After Release of the US Medical Eligibility Criteria for Contraceptive Use

Tools:

Journal Title:

Preventing Chronic Disease

Volume:

Volume 16

Publisher:

, Pages E03-E03

Type of Work:

Article | Final Publisher PDF

Abstract:

INTRODUCTION: The US Medical Eligibility Criteria for Contraceptive Use (MEC) identified 20 medical conditions that increase a woman's risk for adverse outcomes in pregnancy. MEC recommends that women with these conditions use long-acting, highly effective contraceptive methods. The objective of our study was to examine provision of contraception to women enrolled in Medicaid who had 1 or more of these 20 medical conditions METHODS: We used Medicaid Analytic Extract claims data to study Medicaid-enrolled women who were of reproductive age in the 2-year period before MEC's release (2008 and 2009) (N = 442,424) and the 2-year period after its release (2011 and 2012) (N = 533,619) for 14 states. We assessed 2 outcomes: provision of family planning management (FPM) and provision of highest efficacy methods (HEMs) for the entire study population and by health condition. The ratio of the after-MEC rate to the before-MEC rate was used to determine significance in MEC's uptake. RESULTS: Outcomes increased significantly from the before-MEC period to the after-MEC period for both FPM (1.06; lower bound confidence interval [CI], 1.05) and HEM (1.37; lower bound CI, 1.36) for a 1-sided hypothesis test. For the 19 of 20 conditions we were able to test for FPM, contraceptive use increased significantly for 12 conditions, with ratios ranging from 1.05 to 2.14. For the 16 of 20 conditions tested for HEM, contraception use increased significantly for all conditions, with ratios ranging from 1.19 to 2.80. CONCLUSION: Provision of both FPM and HEM increased significantly among women with high-risk health conditions from the before-MEC period (2008 and 2009) to the after-MEC period (2011 and 2012). Health policy makers and clinicians need to continue promotion of effective family planning management for women with high-risk conditions.

Copyright information:

This manuscript was written in the course of employment by the United States Government and it is not subject to copyright in the United States.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote